Nephrol Dial Transplant (2002) 17: 985-991
© 2002 European Renal Association-European Dialysis and Transplant Association
Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats
1 Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, 2 Department of Physiology, University of Melbourne, Parkville and 3 Department of Anatomy and Cell Biology, Monash University, Clayton, Victoria, Australia
Background. Osteopontin is a macrophage chemotactic protein that has been pathogenetically linked to tissue injury in non-diabetic kidney disease.
Methods. To examine osteopontin expression and macrophage accumulation in diabetic nephropathy, diabetes was induced with streptozotocin (STZ) in the transgenic (mRen-2)27 rat, a rodent model which develops the structural and functional features of its human counterpart when rendered diabetic. Non-diabetic rats were randomly selected to receive either (STZ) or citrate buffer. Diabetic rats were further randomly selected to receive either the angiotensin-converting-enzyme inhibitor, perindopril (6 mg/kg/day), or the vehicle only for 12 weeks.
Results. When compared with control animals, diabetes was associated with a 10-fold increase in the gene expression of osteopontin. Increased transcript and immunostainable osteopontin were detected in tubular epithelial cells in association with extensive macrophage accumulation. Treatment with perindopril significantly ameliorated the overexpression of osteopontin in association with attenuation of macrophage accumulation.
Conclusions. These findings suggest that osteopontin expression and macrophage accumulation may play a role in the tubulointerstitial injury in diabetic nephropathy, and that inhibition of osteopontin expression may be one of the mechanisms by which blockade of the renin-angiotensin system confers a renoprotective effect.
Keywords: diabetes; kidney; macrophage; osteopontin
Correspondence and offprint requests to: Dr Darren J. Kelly, Department of Medicine, St Vincent's Hospital, Fitzroy, Victoria, 3065, Australia. Email: dkelly{at}medstv.unimelb.edu.au
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Reungjui, C. A. Roncal, W. Sato, O. Y. Glushakova, B. P. Croker, S.-i. Suga, X. Ouyang, K. Tungsanga, T. Nakagawa, R. J. Johnson, et al. Hypokalemic Nephropathy is Associated with Impaired Angiogenesis J. Am. Soc. Nephrol., January 1, 2008; 19(1): 125 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. Usui, K. Shikata, M. Sasaki, S. Okada, M. Matsuda, Y. Shikata, D. Ogawa, Y. Kido, R. Nagase, K. Yozai, et al. Macrophage Scavenger Receptor-A-Deficient Mice Are Resistant Against Diabetic Nephropathy Through Amelioration of Microinflammation Diabetes, February 1, 2007; 56(2): 363 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hartner, N. Cordasic, B. Klanke, M. Wittmann, R. Veelken, and K. F. Hilgers Renal injury in streptozotocin-diabetic Ren2-transgenic rats is mainly dependent on hypertension, not on diabetes Am J Physiol Renal Physiol, February 1, 2007; 292(2): F820 - F827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Guo, D. Martinez-Vasquez, G. P. Mendez, M. F. Toniolo, T. M. Yao, E. M. Oestreicher, T. Kikuchi, N. Lapointe, L. Pojoga, G. H. Williams, et al. Mineralocorticoid Receptor Antagonist Reduces Renal Injury in Rodent Models of Types 1 and 2 Diabetes Mellitus Endocrinology, November 1, 2006; 147(11): 5363 - 5373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Susztak, E. Bottinger, A. Novetsky, D. Liang, Y. Zhu, E. Ciccone, D. Wu, S. Dunn, P. McCue, and K. Sharma Molecular Profiling of Diabetic Mouse Kidney Reveals Novel Genes Linked to Glomerular Disease Diabetes, March 1, 2004; 53(3): 784 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Umekawa, Y. Hatanaka, T. Kurita, and S. R. Khan Effect of Angiotensin II Receptor Blockage on Osteopontin Expression and Calcium Oxalate Crystal Deposition in Rat Kidneys J. Am. Soc. Nephrol., March 1, 2004; 15(3): 635 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Li, C. W. Yang, W. Y. Kim, J. Y. Jung, J. H. Cha, Y. S. Kim, J. Kim, W. M. Bennett, and B. K. Bang Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine Am J Physiol Renal Physiol, February 1, 2003; 284(2): F389 - F398. [Abstract] [Full Text] [PDF]
|
|